nodes	percent_of_prediction	percent_of_DWPC	metapath
Galantamine—CHRNA5—Nicotine—ulcerative colitis	0.147	0.167	CbGbCtD
Galantamine—CHRNB3—Nicotine—ulcerative colitis	0.147	0.167	CbGbCtD
Galantamine—CHRNA9—Nicotine—ulcerative colitis	0.147	0.167	CbGbCtD
Galantamine—CHRNB2—Nicotine—ulcerative colitis	0.0844	0.0959	CbGbCtD
Galantamine—CHRNA6—Nicotine—ulcerative colitis	0.0844	0.0959	CbGbCtD
Galantamine—CHRNA10—Nicotine—ulcerative colitis	0.0539	0.0613	CbGbCtD
Galantamine—CHRNB4—Nicotine—ulcerative colitis	0.0485	0.0551	CbGbCtD
Galantamine—CHRNA3—Nicotine—ulcerative colitis	0.0405	0.0461	CbGbCtD
Galantamine—CHRNA2—Nicotine—ulcerative colitis	0.0243	0.0276	CbGbCtD
Galantamine—CHRFAM7A—Nicotine—ulcerative colitis	0.0243	0.0276	CbGbCtD
Galantamine—CHRNA4—Nicotine—ulcerative colitis	0.0243	0.0276	CbGbCtD
Galantamine—CHRNA7—Nicotine—ulcerative colitis	0.0243	0.0276	CbGbCtD
Galantamine—BCHE—Triamcinolone—ulcerative colitis	0.00884	0.01	CbGbCtD
Galantamine—CYP3A4—Budesonide—ulcerative colitis	0.00397	0.00451	CbGbCtD
Galantamine—CYP2D6—Nicotine—ulcerative colitis	0.00272	0.00309	CbGbCtD
Galantamine—CYP2D6—Cholecalciferol—ulcerative colitis	0.00244	0.00277	CbGbCtD
Galantamine—CYP3A4—Methylprednisolone—ulcerative colitis	0.00177	0.00202	CbGbCtD
Galantamine—CYP3A4—Nicotine—ulcerative colitis	0.00173	0.00196	CbGbCtD
Galantamine—CYP3A4—Cholecalciferol—ulcerative colitis	0.00155	0.00176	CbGbCtD
Galantamine—CYP3A4—Triamcinolone—ulcerative colitis	0.00134	0.00153	CbGbCtD
Galantamine—CYP3A4—Betamethasone—ulcerative colitis	0.00115	0.00131	CbGbCtD
Galantamine—CYP3A4—Prednisolone—ulcerative colitis	0.00114	0.00129	CbGbCtD
Galantamine—CYP3A4—Hydrocortisone—ulcerative colitis	0.00108	0.00123	CbGbCtD
Galantamine—CYP3A4—Prednisone—ulcerative colitis	0.00107	0.00122	CbGbCtD
Galantamine—CYP2D6—Dexamethasone—ulcerative colitis	0.00106	0.0012	CbGbCtD
Galantamine—CYP3A4—Dexamethasone—ulcerative colitis	0.000671	0.000762	CbGbCtD
Galantamine—ACHE—Synthesis, secretion, and deacylation of Ghrelin—GHRL—ulcerative colitis	0.000171	0.0228	CbGpPWpGaD
Galantamine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—GHRL—ulcerative colitis	0.000152	0.0203	CbGpPWpGaD
Galantamine—ACHE—ATF-2 transcription factor network—IL23A—ulcerative colitis	0.000145	0.0193	CbGpPWpGaD
Galantamine—CHRNA9—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM3—ulcerative colitis	0.000139	0.0186	CbGpPWpGaD
Galantamine—CHRNE—ErbB2/ErbB3 signaling events—JAK2—ulcerative colitis	0.000125	0.0167	CbGpPWpGaD
Galantamine—CHRNB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM3—ulcerative colitis	0.000122	0.0162	CbGpPWpGaD
Galantamine—CHRNA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM3—ulcerative colitis	0.000115	0.0154	CbGpPWpGaD
Galantamine—CHRNG—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM3—ulcerative colitis	0.00011	0.0147	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—RUNX3—ulcerative colitis	0.000108	0.0144	CbGpPWpGaD
Galantamine—CHRNA9—Transmission across Chemical Synapses—CALM3—ulcerative colitis	0.000105	0.014	CbGpPWpGaD
Galantamine—CHRNE—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM3—ulcerative colitis	0.000104	0.0138	CbGpPWpGaD
Galantamine—CHRNA9—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—ulcerative colitis	0.000101	0.0135	CbGpPWpGaD
Galantamine—CYP2D6—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	9.64e-05	0.0129	CbGpPWpGaD
Galantamine—CHRNE—ErbB2/ErbB3 signaling events—STAT3—ulcerative colitis	9.18e-05	0.0123	CbGpPWpGaD
Galantamine—CHRNB3—Transmission across Chemical Synapses—CALM3—ulcerative colitis	9.15e-05	0.0122	CbGpPWpGaD
Galantamine—Convulsion—Hydrocortisone—ulcerative colitis	8.99e-05	0.000799	CcSEcCtD
Galantamine—Hypertension—Hydrocortisone—ulcerative colitis	8.96e-05	0.000796	CcSEcCtD
Galantamine—Diarrhoea—Azathioprine—ulcerative colitis	8.95e-05	0.000795	CcSEcCtD
Galantamine—Discomfort—Prednisolone—ulcerative colitis	8.94e-05	0.000794	CcSEcCtD
Galantamine—Haemoglobin—Prednisone—ulcerative colitis	8.92e-05	0.000792	CcSEcCtD
Galantamine—Haemorrhage—Prednisone—ulcerative colitis	8.87e-05	0.000788	CcSEcCtD
Galantamine—Myalgia—Hydrocortisone—ulcerative colitis	8.84e-05	0.000785	CcSEcCtD
Galantamine—CHRNB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—ulcerative colitis	8.83e-05	0.0118	CbGpPWpGaD
Galantamine—Hallucination—Prednisone—ulcerative colitis	8.83e-05	0.000784	CcSEcCtD
Galantamine—Malaise—Triamcinolone—ulcerative colitis	8.81e-05	0.000783	CcSEcCtD
Galantamine—Anxiety—Hydrocortisone—ulcerative colitis	8.8e-05	0.000782	CcSEcCtD
Galantamine—Malaise—Methylprednisolone—ulcerative colitis	8.79e-05	0.000781	CcSEcCtD
Galantamine—Vertigo—Triamcinolone—ulcerative colitis	8.78e-05	0.00078	CcSEcCtD
Galantamine—Hypersensitivity—Mesalazine—ulcerative colitis	8.78e-05	0.000779	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	8.77e-05	0.000779	CcSEcCtD
Galantamine—Syncope—Triamcinolone—ulcerative colitis	8.76e-05	0.000778	CcSEcCtD
Galantamine—Vertigo—Methylprednisolone—ulcerative colitis	8.76e-05	0.000778	CcSEcCtD
Galantamine—CHRNA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM3—ulcerative colitis	8.75e-05	0.0117	CbGpPWpGaD
Galantamine—Syncope—Methylprednisolone—ulcerative colitis	8.74e-05	0.000776	CcSEcCtD
Galantamine—Discomfort—Hydrocortisone—ulcerative colitis	8.73e-05	0.000775	CcSEcCtD
Galantamine—Connective tissue disorder—Prednisone—ulcerative colitis	8.72e-05	0.000774	CcSEcCtD
Galantamine—Nausea—Budesonide—ulcerative colitis	8.7e-05	0.000773	CcSEcCtD
Galantamine—CHRNA5—Transmission across Chemical Synapses—CALM3—ulcerative colitis	8.68e-05	0.0116	CbGpPWpGaD
Galantamine—Dizziness—Azathioprine—ulcerative colitis	8.65e-05	0.000768	CcSEcCtD
Galantamine—Loss of consciousness—Triamcinolone—ulcerative colitis	8.59e-05	0.000763	CcSEcCtD
Galantamine—Loss of consciousness—Methylprednisolone—ulcerative colitis	8.57e-05	0.000761	CcSEcCtD
Galantamine—Asthenia—Mesalazine—ulcerative colitis	8.55e-05	0.000759	CcSEcCtD
Galantamine—Shock—Prednisolone—ulcerative colitis	8.53e-05	0.000758	CcSEcCtD
Galantamine—Cough—Triamcinolone—ulcerative colitis	8.53e-05	0.000757	CcSEcCtD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—RUNX3—ulcerative colitis	8.5e-05	0.0113	CbGpPWpGaD
Galantamine—Convulsion—Triamcinolone—ulcerative colitis	8.47e-05	0.000752	CcSEcCtD
Galantamine—Tachycardia—Prednisolone—ulcerative colitis	8.46e-05	0.000752	CcSEcCtD
Galantamine—Convulsion—Methylprednisolone—ulcerative colitis	8.45e-05	0.00075	CcSEcCtD
Galantamine—Hypertension—Triamcinolone—ulcerative colitis	8.44e-05	0.000749	CcSEcCtD
Galantamine—Hypertension—Methylprednisolone—ulcerative colitis	8.42e-05	0.000748	CcSEcCtD
Galantamine—Hyperhidrosis—Prednisolone—ulcerative colitis	8.38e-05	0.000745	CcSEcCtD
Galantamine—CHRNA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—ulcerative colitis	8.37e-05	0.0112	CbGpPWpGaD
Galantamine—Shock—Hydrocortisone—ulcerative colitis	8.33e-05	0.00074	CcSEcCtD
Galantamine—Myalgia—Triamcinolone—ulcerative colitis	8.32e-05	0.000739	CcSEcCtD
Galantamine—Vomiting—Azathioprine—ulcerative colitis	8.31e-05	0.000738	CcSEcCtD
Galantamine—Nervous system disorder—Hydrocortisone—ulcerative colitis	8.31e-05	0.000738	CcSEcCtD
Galantamine—Arthralgia—Methylprednisolone—ulcerative colitis	8.3e-05	0.000737	CcSEcCtD
Galantamine—Myalgia—Methylprednisolone—ulcerative colitis	8.3e-05	0.000737	CcSEcCtD
Galantamine—Eye disorder—Prednisone—ulcerative colitis	8.29e-05	0.000736	CcSEcCtD
Galantamine—CHRNG—Transmission across Chemical Synapses—CALM3—ulcerative colitis	8.28e-05	0.011	CbGpPWpGaD
Galantamine—Anxiety—Methylprednisolone—ulcerative colitis	8.27e-05	0.000735	CcSEcCtD
Galantamine—Tachycardia—Hydrocortisone—ulcerative colitis	8.27e-05	0.000734	CcSEcCtD
Galantamine—Rash—Azathioprine—ulcerative colitis	8.24e-05	0.000732	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	8.24e-05	0.000732	CcSEcCtD
Galantamine—Dermatitis—Azathioprine—ulcerative colitis	8.24e-05	0.000731	CcSEcCtD
Galantamine—Flushing—Prednisone—ulcerative colitis	8.23e-05	0.000731	CcSEcCtD
Galantamine—Skin disorder—Hydrocortisone—ulcerative colitis	8.23e-05	0.000731	CcSEcCtD
Galantamine—Ill-defined disorder—Betamethasone—ulcerative colitis	8.23e-05	0.000731	CcSEcCtD
Galantamine—Ill-defined disorder—Dexamethasone—ulcerative colitis	8.23e-05	0.000731	CcSEcCtD
Galantamine—Discomfort—Triamcinolone—ulcerative colitis	8.22e-05	0.00073	CcSEcCtD
Galantamine—Discomfort—Methylprednisolone—ulcerative colitis	8.2e-05	0.000728	CcSEcCtD
Galantamine—Headache—Azathioprine—ulcerative colitis	8.19e-05	0.000727	CcSEcCtD
Galantamine—Hyperhidrosis—Hydrocortisone—ulcerative colitis	8.19e-05	0.000727	CcSEcCtD
Galantamine—Diarrhoea—Mesalazine—ulcerative colitis	8.15e-05	0.000724	CcSEcCtD
Galantamine—Dry mouth—Triamcinolone—ulcerative colitis	8.14e-05	0.000723	CcSEcCtD
Galantamine—Anorexia—Hydrocortisone—ulcerative colitis	8.07e-05	0.000717	CcSEcCtD
Galantamine—Angiopathy—Prednisone—ulcerative colitis	8.05e-05	0.000715	CcSEcCtD
Galantamine—Confusional state—Methylprednisolone—ulcerative colitis	8.02e-05	0.000713	CcSEcCtD
Galantamine—CHRNA9—Neuronal System—CALM3—ulcerative colitis	8.02e-05	0.0107	CbGpPWpGaD
Galantamine—Immune system disorder—Prednisone—ulcerative colitis	8.01e-05	0.000712	CcSEcCtD
Galantamine—Malaise—Betamethasone—ulcerative colitis	8e-05	0.00071	CcSEcCtD
Galantamine—Malaise—Dexamethasone—ulcerative colitis	8e-05	0.00071	CcSEcCtD
Galantamine—CHRNG—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—ulcerative colitis	7.99e-05	0.0107	CbGpPWpGaD
Galantamine—Vertigo—Betamethasone—ulcerative colitis	7.97e-05	0.000707	CcSEcCtD
Galantamine—Vertigo—Dexamethasone—ulcerative colitis	7.97e-05	0.000707	CcSEcCtD
Galantamine—Syncope—Betamethasone—ulcerative colitis	7.95e-05	0.000706	CcSEcCtD
Galantamine—Syncope—Dexamethasone—ulcerative colitis	7.95e-05	0.000706	CcSEcCtD
Galantamine—Arrhythmia—Prednisone—ulcerative colitis	7.92e-05	0.000704	CcSEcCtD
Galantamine—Hypotension—Hydrocortisone—ulcerative colitis	7.91e-05	0.000703	CcSEcCtD
Galantamine—Dizziness—Mesalazine—ulcerative colitis	7.88e-05	0.000699	CcSEcCtD
Galantamine—Shock—Triamcinolone—ulcerative colitis	7.85e-05	0.000697	CcSEcCtD
Galantamine—Insomnia—Prednisolone—ulcerative colitis	7.84e-05	0.000697	CcSEcCtD
Galantamine—Shock—Methylprednisolone—ulcerative colitis	7.83e-05	0.000695	CcSEcCtD
Galantamine—Nervous system disorder—Methylprednisolone—ulcerative colitis	7.8e-05	0.000693	CcSEcCtD
Galantamine—Loss of consciousness—Betamethasone—ulcerative colitis	7.79e-05	0.000692	CcSEcCtD
Galantamine—Loss of consciousness—Dexamethasone—ulcerative colitis	7.79e-05	0.000692	CcSEcCtD
Galantamine—Paraesthesia—Prednisolone—ulcerative colitis	7.79e-05	0.000692	CcSEcCtD
Galantamine—Tachycardia—Triamcinolone—ulcerative colitis	7.78e-05	0.000691	CcSEcCtD
Galantamine—CHRNE—Transmission across Chemical Synapses—CALM3—ulcerative colitis	7.78e-05	0.0104	CbGpPWpGaD
Galantamine—Mental disorder—Prednisone—ulcerative colitis	7.77e-05	0.00069	CcSEcCtD
Galantamine—Nausea—Azathioprine—ulcerative colitis	7.77e-05	0.00069	CcSEcCtD
Galantamine—Tachycardia—Methylprednisolone—ulcerative colitis	7.77e-05	0.00069	CcSEcCtD
Galantamine—Skin disorder—Methylprednisolone—ulcerative colitis	7.73e-05	0.000686	CcSEcCtD
Galantamine—Malnutrition—Prednisone—ulcerative colitis	7.72e-05	0.000686	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	7.72e-05	0.000685	CcSEcCtD
Galantamine—Hyperhidrosis—Triamcinolone—ulcerative colitis	7.71e-05	0.000685	CcSEcCtD
Galantamine—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM3—ulcerative colitis	7.7e-05	0.0103	CbGpPWpGaD
Galantamine—Hyperhidrosis—Methylprednisolone—ulcerative colitis	7.69e-05	0.000683	CcSEcCtD
Galantamine—Convulsion—Betamethasone—ulcerative colitis	7.68e-05	0.000682	CcSEcCtD
Galantamine—Convulsion—Dexamethasone—ulcerative colitis	7.68e-05	0.000682	CcSEcCtD
Galantamine—Insomnia—Hydrocortisone—ulcerative colitis	7.66e-05	0.00068	CcSEcCtD
Galantamine—Hypertension—Betamethasone—ulcerative colitis	7.66e-05	0.00068	CcSEcCtD
Galantamine—Hypertension—Dexamethasone—ulcerative colitis	7.66e-05	0.00068	CcSEcCtD
Galantamine—Paraesthesia—Hydrocortisone—ulcerative colitis	7.61e-05	0.000675	CcSEcCtD
Galantamine—CHRNA9—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	7.6e-05	0.0101	CbGpPWpGaD
Galantamine—Vomiting—Mesalazine—ulcerative colitis	7.57e-05	0.000673	CcSEcCtD
Galantamine—Myalgia—Betamethasone—ulcerative colitis	7.55e-05	0.00067	CcSEcCtD
Galantamine—Myalgia—Dexamethasone—ulcerative colitis	7.55e-05	0.00067	CcSEcCtD
Galantamine—Anxiety—Betamethasone—ulcerative colitis	7.52e-05	0.000668	CcSEcCtD
Galantamine—Anxiety—Dexamethasone—ulcerative colitis	7.52e-05	0.000668	CcSEcCtD
Galantamine—Rash—Mesalazine—ulcerative colitis	7.51e-05	0.000667	CcSEcCtD
Galantamine—CHRNE—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—ulcerative colitis	7.51e-05	0.01	CbGpPWpGaD
Galantamine—Dermatitis—Mesalazine—ulcerative colitis	7.5e-05	0.000666	CcSEcCtD
Galantamine—Headache—Mesalazine—ulcerative colitis	7.46e-05	0.000663	CcSEcCtD
Galantamine—Discomfort—Dexamethasone—ulcerative colitis	7.46e-05	0.000662	CcSEcCtD
Galantamine—Discomfort—Betamethasone—ulcerative colitis	7.46e-05	0.000662	CcSEcCtD
Galantamine—Dyspepsia—Hydrocortisone—ulcerative colitis	7.46e-05	0.000662	CcSEcCtD
Galantamine—Hypotension—Methylprednisolone—ulcerative colitis	7.44e-05	0.00066	CcSEcCtD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—RUNX3—ulcerative colitis	7.38e-05	0.00985	CbGpPWpGaD
Galantamine—Decreased appetite—Hydrocortisone—ulcerative colitis	7.36e-05	0.000654	CcSEcCtD
Galantamine—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	7.31e-05	0.000649	CcSEcCtD
Galantamine—Fatigue—Hydrocortisone—ulcerative colitis	7.3e-05	0.000648	CcSEcCtD
Galantamine—Vision blurred—Prednisone—ulcerative colitis	7.28e-05	0.000646	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	7.27e-05	0.000645	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	7.25e-05	0.000644	CcSEcCtD
Galantamine—Insomnia—Triamcinolone—ulcerative colitis	7.21e-05	0.000641	CcSEcCtD
Galantamine—Insomnia—Methylprednisolone—ulcerative colitis	7.2e-05	0.000639	CcSEcCtD
Galantamine—Ill-defined disorder—Prednisone—ulcerative colitis	7.16e-05	0.000636	CcSEcCtD
Galantamine—Paraesthesia—Triamcinolone—ulcerative colitis	7.16e-05	0.000636	CcSEcCtD
Galantamine—Feeling abnormal—Prednisolone—ulcerative colitis	7.15e-05	0.000635	CcSEcCtD
Galantamine—Paraesthesia—Methylprednisolone—ulcerative colitis	7.15e-05	0.000635	CcSEcCtD
Galantamine—Anaemia—Prednisone—ulcerative colitis	7.14e-05	0.000634	CcSEcCtD
Galantamine—Shock—Dexamethasone—ulcerative colitis	7.12e-05	0.000632	CcSEcCtD
Galantamine—Shock—Betamethasone—ulcerative colitis	7.12e-05	0.000632	CcSEcCtD
Galantamine—Nervous system disorder—Betamethasone—ulcerative colitis	7.1e-05	0.00063	CcSEcCtD
Galantamine—Nervous system disorder—Dexamethasone—ulcerative colitis	7.1e-05	0.00063	CcSEcCtD
Galantamine—Agitation—Prednisone—ulcerative colitis	7.1e-05	0.00063	CcSEcCtD
Galantamine—Thrombocytopenia—Betamethasone—ulcerative colitis	7.09e-05	0.000629	CcSEcCtD
Galantamine—Thrombocytopenia—Dexamethasone—ulcerative colitis	7.09e-05	0.000629	CcSEcCtD
Galantamine—Nausea—Mesalazine—ulcerative colitis	7.08e-05	0.000628	CcSEcCtD
Galantamine—Tachycardia—Betamethasone—ulcerative colitis	7.06e-05	0.000627	CcSEcCtD
Galantamine—Tachycardia—Dexamethasone—ulcerative colitis	7.06e-05	0.000627	CcSEcCtD
Galantamine—Dyspepsia—Triamcinolone—ulcerative colitis	7.02e-05	0.000623	CcSEcCtD
Galantamine—CHRNB3—Neuronal System—CALM3—ulcerative colitis	7.01e-05	0.00936	CbGpPWpGaD
Galantamine—Dyspepsia—Methylprednisolone—ulcerative colitis	7e-05	0.000622	CcSEcCtD
Galantamine—Hyperhidrosis—Betamethasone—ulcerative colitis	7e-05	0.000621	CcSEcCtD
Galantamine—Hyperhidrosis—Dexamethasone—ulcerative colitis	7e-05	0.000621	CcSEcCtD
Galantamine—Feeling abnormal—Hydrocortisone—ulcerative colitis	6.98e-05	0.00062	CcSEcCtD
Galantamine—Malaise—Prednisone—ulcerative colitis	6.96e-05	0.000618	CcSEcCtD
Galantamine—Vertigo—Prednisone—ulcerative colitis	6.94e-05	0.000616	CcSEcCtD
Galantamine—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	6.93e-05	0.000615	CcSEcCtD
Galantamine—Syncope—Prednisone—ulcerative colitis	6.92e-05	0.000615	CcSEcCtD
Galantamine—Anorexia—Dexamethasone—ulcerative colitis	6.9e-05	0.000613	CcSEcCtD
Galantamine—Anorexia—Betamethasone—ulcerative colitis	6.9e-05	0.000613	CcSEcCtD
Galantamine—Fatigue—Triamcinolone—ulcerative colitis	6.88e-05	0.000611	CcSEcCtD
Galantamine—Fatigue—Methylprednisolone—ulcerative colitis	6.86e-05	0.000609	CcSEcCtD
Galantamine—Loss of consciousness—Prednisone—ulcerative colitis	6.79e-05	0.000603	CcSEcCtD
Galantamine—Hypotension—Dexamethasone—ulcerative colitis	6.76e-05	0.0006	CcSEcCtD
Galantamine—Hypotension—Betamethasone—ulcerative colitis	6.76e-05	0.0006	CcSEcCtD
Galantamine—Abdominal pain—Hydrocortisone—ulcerative colitis	6.7e-05	0.000595	CcSEcCtD
Galantamine—Body temperature increased—Hydrocortisone—ulcerative colitis	6.7e-05	0.000595	CcSEcCtD
Galantamine—Convulsion—Prednisone—ulcerative colitis	6.69e-05	0.000594	CcSEcCtD
Galantamine—Hypertension—Prednisone—ulcerative colitis	6.67e-05	0.000592	CcSEcCtD
Galantamine—CHRNA5—Neuronal System—CALM3—ulcerative colitis	6.65e-05	0.00887	CbGpPWpGaD
Galantamine—CHRNB3—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	6.64e-05	0.00886	CbGpPWpGaD
Galantamine—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	6.59e-05	0.000585	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	6.59e-05	0.000585	CcSEcCtD
Galantamine—CHRNA6—Transmission across Chemical Synapses—CALM3—ulcerative colitis	6.58e-05	0.00878	CbGpPWpGaD
Galantamine—Myalgia—Prednisone—ulcerative colitis	6.57e-05	0.000584	CcSEcCtD
Galantamine—Arthralgia—Prednisone—ulcerative colitis	6.57e-05	0.000584	CcSEcCtD
Galantamine—Feeling abnormal—Triamcinolone—ulcerative colitis	6.57e-05	0.000584	CcSEcCtD
Galantamine—Feeling abnormal—Methylprednisolone—ulcerative colitis	6.56e-05	0.000582	CcSEcCtD
Galantamine—Anxiety—Prednisone—ulcerative colitis	6.55e-05	0.000582	CcSEcCtD
Galantamine—Insomnia—Betamethasone—ulcerative colitis	6.55e-05	0.000581	CcSEcCtD
Galantamine—Insomnia—Dexamethasone—ulcerative colitis	6.55e-05	0.000581	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	6.53e-05	0.00058	CcSEcCtD
Galantamine—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	6.51e-05	0.000578	CcSEcCtD
Galantamine—Paraesthesia—Dexamethasone—ulcerative colitis	6.5e-05	0.000577	CcSEcCtD
Galantamine—Paraesthesia—Betamethasone—ulcerative colitis	6.5e-05	0.000577	CcSEcCtD
Galantamine—Discomfort—Prednisone—ulcerative colitis	6.5e-05	0.000577	CcSEcCtD
Galantamine—Hypersensitivity—Prednisolone—ulcerative colitis	6.39e-05	0.000567	CcSEcCtD
Galantamine—Dyspepsia—Betamethasone—ulcerative colitis	6.37e-05	0.000566	CcSEcCtD
Galantamine—Dyspepsia—Dexamethasone—ulcerative colitis	6.37e-05	0.000566	CcSEcCtD
Galantamine—CHRNA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—ulcerative colitis	6.35e-05	0.00847	CbGpPWpGaD
Galantamine—CHRNG—Neuronal System—CALM3—ulcerative colitis	6.34e-05	0.00846	CbGpPWpGaD
Galantamine—Body temperature increased—Triamcinolone—ulcerative colitis	6.3e-05	0.00056	CcSEcCtD
Galantamine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	6.3e-05	0.00841	CbGpPWpGaD
Galantamine—CHRNA5—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	6.29e-05	0.0084	CbGpPWpGaD
Galantamine—Abdominal pain—Methylprednisolone—ulcerative colitis	6.29e-05	0.000559	CcSEcCtD
Galantamine—Decreased appetite—Betamethasone—ulcerative colitis	6.29e-05	0.000559	CcSEcCtD
Galantamine—Decreased appetite—Dexamethasone—ulcerative colitis	6.29e-05	0.000559	CcSEcCtD
Galantamine—CHRNA1—ErbB2/ErbB3 signaling events—JAK2—ulcerative colitis	6.29e-05	0.0084	CbGpPWpGaD
Galantamine—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	6.25e-05	0.000555	CcSEcCtD
Galantamine—Gastrointestinal disorder—Betamethasone—ulcerative colitis	6.25e-05	0.000555	CcSEcCtD
Galantamine—Hypersensitivity—Hydrocortisone—ulcerative colitis	6.24e-05	0.000554	CcSEcCtD
Galantamine—Fatigue—Dexamethasone—ulcerative colitis	6.24e-05	0.000554	CcSEcCtD
Galantamine—Fatigue—Betamethasone—ulcerative colitis	6.24e-05	0.000554	CcSEcCtD
Galantamine—Shock—Prednisone—ulcerative colitis	6.2e-05	0.000551	CcSEcCtD
Galantamine—Nervous system disorder—Prednisone—ulcerative colitis	6.18e-05	0.000549	CcSEcCtD
Galantamine—Tachycardia—Prednisone—ulcerative colitis	6.15e-05	0.000546	CcSEcCtD
Galantamine—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM3—ulcerative colitis	6.12e-05	0.00817	CbGpPWpGaD
Galantamine—Skin disorder—Prednisone—ulcerative colitis	6.12e-05	0.000544	CcSEcCtD
Galantamine—Hyperhidrosis—Prednisone—ulcerative colitis	6.09e-05	0.000541	CcSEcCtD
Galantamine—Asthenia—Hydrocortisone—ulcerative colitis	6.08e-05	0.00054	CcSEcCtD
Galantamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM3—ulcerative colitis	6.06e-05	0.00809	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—RUNX3—ulcerative colitis	6.01e-05	0.00803	CbGpPWpGaD
Galantamine—Anorexia—Prednisone—ulcerative colitis	6.01e-05	0.000533	CcSEcCtD
Galantamine—CHRNG—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	6e-05	0.00801	CbGpPWpGaD
Galantamine—Feeling abnormal—Betamethasone—ulcerative colitis	5.96e-05	0.00053	CcSEcCtD
Galantamine—Feeling abnormal—Dexamethasone—ulcerative colitis	5.96e-05	0.00053	CcSEcCtD
Galantamine—CHRNE—Neuronal System—CALM3—ulcerative colitis	5.96e-05	0.00796	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—GHRL—ulcerative colitis	5.95e-05	0.00795	CbGpPWpGaD
Galantamine—Gastrointestinal pain—Betamethasone—ulcerative colitis	5.92e-05	0.000525	CcSEcCtD
Galantamine—Gastrointestinal pain—Dexamethasone—ulcerative colitis	5.92e-05	0.000525	CcSEcCtD
Galantamine—Hypersensitivity—Triamcinolone—ulcerative colitis	5.88e-05	0.000522	CcSEcCtD
Galantamine—Hypersensitivity—Methylprednisolone—ulcerative colitis	5.86e-05	0.000521	CcSEcCtD
Galantamine—CHRNA9—Neuronal System—ADCY5—ulcerative colitis	5.82e-05	0.00777	CbGpPWpGaD
Galantamine—Diarrhoea—Hydrocortisone—ulcerative colitis	5.8e-05	0.000515	CcSEcCtD
Galantamine—CHRNB2—Transmission across Chemical Synapses—CALM3—ulcerative colitis	5.79e-05	0.00773	CbGpPWpGaD
Galantamine—Musculoskeletal discomfort—Prednisone—ulcerative colitis	5.74e-05	0.00051	CcSEcCtD
Galantamine—Dizziness—Prednisolone—ulcerative colitis	5.73e-05	0.000509	CcSEcCtD
Galantamine—Asthenia—Triamcinolone—ulcerative colitis	5.72e-05	0.000508	CcSEcCtD
Galantamine—Body temperature increased—Betamethasone—ulcerative colitis	5.72e-05	0.000508	CcSEcCtD
Galantamine—Body temperature increased—Dexamethasone—ulcerative colitis	5.72e-05	0.000508	CcSEcCtD
Galantamine—Abdominal pain—Dexamethasone—ulcerative colitis	5.72e-05	0.000508	CcSEcCtD
Galantamine—Abdominal pain—Betamethasone—ulcerative colitis	5.72e-05	0.000508	CcSEcCtD
Galantamine—Asthenia—Methylprednisolone—ulcerative colitis	5.71e-05	0.000507	CcSEcCtD
Galantamine—Insomnia—Prednisone—ulcerative colitis	5.7e-05	0.000506	CcSEcCtD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	5.66e-05	0.00756	CbGpPWpGaD
Galantamine—Paraesthesia—Prednisone—ulcerative colitis	5.66e-05	0.000503	CcSEcCtD
Galantamine—CHRNE—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	5.65e-05	0.00754	CbGpPWpGaD
Galantamine—Dizziness—Hydrocortisone—ulcerative colitis	5.6e-05	0.000497	CcSEcCtD
Galantamine—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—ulcerative colitis	5.59e-05	0.00746	CbGpPWpGaD
Galantamine—Dyspepsia—Prednisone—ulcerative colitis	5.55e-05	0.000493	CcSEcCtD
Galantamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM3—ulcerative colitis	5.54e-05	0.0074	CbGpPWpGaD
Galantamine—Decreased appetite—Prednisone—ulcerative colitis	5.48e-05	0.000486	CcSEcCtD
Galantamine—Rash—Prednisolone—ulcerative colitis	5.47e-05	0.000486	CcSEcCtD
Galantamine—Dermatitis—Prednisolone—ulcerative colitis	5.46e-05	0.000485	CcSEcCtD
Galantamine—Diarrhoea—Methylprednisolone—ulcerative colitis	5.44e-05	0.000484	CcSEcCtD
Galantamine—Fatigue—Prednisone—ulcerative colitis	5.43e-05	0.000482	CcSEcCtD
Galantamine—Headache—Prednisolone—ulcerative colitis	5.43e-05	0.000482	CcSEcCtD
Galantamine—Constipation—Prednisone—ulcerative colitis	5.39e-05	0.000479	CcSEcCtD
Galantamine—Vomiting—Hydrocortisone—ulcerative colitis	5.39e-05	0.000478	CcSEcCtD
Galantamine—Rash—Hydrocortisone—ulcerative colitis	5.34e-05	0.000474	CcSEcCtD
Galantamine—Dermatitis—Hydrocortisone—ulcerative colitis	5.34e-05	0.000474	CcSEcCtD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—IL10—ulcerative colitis	5.33e-05	0.00712	CbGpPWpGaD
Galantamine—Headache—Hydrocortisone—ulcerative colitis	5.31e-05	0.000471	CcSEcCtD
Galantamine—Dizziness—Triamcinolone—ulcerative colitis	5.27e-05	0.000468	CcSEcCtD
Galantamine—Dizziness—Methylprednisolone—ulcerative colitis	5.26e-05	0.000467	CcSEcCtD
Galantamine—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM3—ulcerative colitis	5.26e-05	0.00702	CbGpPWpGaD
Galantamine—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM3—ulcerative colitis	5.21e-05	0.00695	CbGpPWpGaD
Galantamine—Feeling abnormal—Prednisone—ulcerative colitis	5.19e-05	0.000461	CcSEcCtD
Galantamine—Asthenia—Dexamethasone—ulcerative colitis	5.19e-05	0.000461	CcSEcCtD
Galantamine—Asthenia—Betamethasone—ulcerative colitis	5.19e-05	0.000461	CcSEcCtD
Galantamine—Gastrointestinal pain—Prednisone—ulcerative colitis	5.15e-05	0.000458	CcSEcCtD
Galantamine—Nausea—Prednisolone—ulcerative colitis	5.15e-05	0.000457	CcSEcCtD
Galantamine—CHRNB3—Neuronal System—ADCY5—ulcerative colitis	5.09e-05	0.00679	CbGpPWpGaD
Galantamine—Vomiting—Triamcinolone—ulcerative colitis	5.07e-05	0.00045	CcSEcCtD
Galantamine—Vomiting—Methylprednisolone—ulcerative colitis	5.06e-05	0.000449	CcSEcCtD
Galantamine—CHRNA6—Neuronal System—CALM3—ulcerative colitis	5.04e-05	0.00672	CbGpPWpGaD
Galantamine—Nausea—Hydrocortisone—ulcerative colitis	5.03e-05	0.000447	CcSEcCtD
Galantamine—Rash—Triamcinolone—ulcerative colitis	5.03e-05	0.000447	CcSEcCtD
Galantamine—Dermatitis—Triamcinolone—ulcerative colitis	5.02e-05	0.000446	CcSEcCtD
Galantamine—Rash—Methylprednisolone—ulcerative colitis	5.02e-05	0.000446	CcSEcCtD
Galantamine—Dermatitis—Methylprednisolone—ulcerative colitis	5.01e-05	0.000445	CcSEcCtD
Galantamine—Headache—Triamcinolone—ulcerative colitis	5e-05	0.000444	CcSEcCtD
Galantamine—Headache—Methylprednisolone—ulcerative colitis	4.99e-05	0.000443	CcSEcCtD
Galantamine—Abdominal pain—Prednisone—ulcerative colitis	4.98e-05	0.000442	CcSEcCtD
Galantamine—Body temperature increased—Prednisone—ulcerative colitis	4.98e-05	0.000442	CcSEcCtD
Galantamine—Diarrhoea—Betamethasone—ulcerative colitis	4.95e-05	0.00044	CcSEcCtD
Galantamine—Diarrhoea—Dexamethasone—ulcerative colitis	4.95e-05	0.00044	CcSEcCtD
Galantamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM3—ulcerative colitis	4.95e-05	0.0066	CbGpPWpGaD
Galantamine—CHRNA5—Neuronal System—ADCY5—ulcerative colitis	4.82e-05	0.00644	CbGpPWpGaD
Galantamine—Dizziness—Dexamethasone—ulcerative colitis	4.79e-05	0.000425	CcSEcCtD
Galantamine—Dizziness—Betamethasone—ulcerative colitis	4.79e-05	0.000425	CcSEcCtD
Galantamine—CHRNA6—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	4.77e-05	0.00637	CbGpPWpGaD
Galantamine—Nausea—Triamcinolone—ulcerative colitis	4.74e-05	0.000421	CcSEcCtD
Galantamine—Nausea—Methylprednisolone—ulcerative colitis	4.73e-05	0.00042	CcSEcCtD
Galantamine—ACHE—Peptide hormone metabolism—GHRL—ulcerative colitis	4.71e-05	0.00629	CbGpPWpGaD
Galantamine—Hypersensitivity—Prednisone—ulcerative colitis	4.64e-05	0.000412	CcSEcCtD
Galantamine—CHRNA1—ErbB2/ErbB3 signaling events—STAT3—ulcerative colitis	4.62e-05	0.00616	CbGpPWpGaD
Galantamine—CHRND—Transmission across Chemical Synapses—CALM3—ulcerative colitis	4.6e-05	0.00615	CbGpPWpGaD
Galantamine—Vomiting—Dexamethasone—ulcerative colitis	4.6e-05	0.000409	CcSEcCtD
Galantamine—Vomiting—Betamethasone—ulcerative colitis	4.6e-05	0.000409	CcSEcCtD
Galantamine—CHRNG—Neuronal System—ADCY5—ulcerative colitis	4.6e-05	0.00614	CbGpPWpGaD
Galantamine—Rash—Betamethasone—ulcerative colitis	4.56e-05	0.000405	CcSEcCtD
Galantamine—Rash—Dexamethasone—ulcerative colitis	4.56e-05	0.000405	CcSEcCtD
Galantamine—Dermatitis—Dexamethasone—ulcerative colitis	4.56e-05	0.000405	CcSEcCtD
Galantamine—Dermatitis—Betamethasone—ulcerative colitis	4.56e-05	0.000405	CcSEcCtD
Galantamine—CHRNB4—Transmission across Chemical Synapses—CALM3—ulcerative colitis	4.56e-05	0.00608	CbGpPWpGaD
Galantamine—Headache—Betamethasone—ulcerative colitis	4.53e-05	0.000403	CcSEcCtD
Galantamine—Headache—Dexamethasone—ulcerative colitis	4.53e-05	0.000403	CcSEcCtD
Galantamine—Asthenia—Prednisone—ulcerative colitis	4.52e-05	0.000402	CcSEcCtD
Galantamine—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—ulcerative colitis	4.44e-05	0.00593	CbGpPWpGaD
Galantamine—CHRNB2—Neuronal System—CALM3—ulcerative colitis	4.44e-05	0.00592	CbGpPWpGaD
Galantamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—ulcerative colitis	4.4e-05	0.00587	CbGpPWpGaD
Galantamine—CHRNE—Neuronal System—ADCY5—ulcerative colitis	4.33e-05	0.00577	CbGpPWpGaD
Galantamine—Diarrhoea—Prednisone—ulcerative colitis	4.31e-05	0.000383	CcSEcCtD
Galantamine—Nausea—Betamethasone—ulcerative colitis	4.3e-05	0.000382	CcSEcCtD
Galantamine—Nausea—Dexamethasone—ulcerative colitis	4.3e-05	0.000382	CcSEcCtD
Galantamine—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM3—ulcerative colitis	4.29e-05	0.00573	CbGpPWpGaD
Galantamine—BCHE—Peptide hormone metabolism—GHRL—ulcerative colitis	4.2e-05	0.00561	CbGpPWpGaD
Galantamine—CHRNB2—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	4.2e-05	0.00561	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—IL10—ulcerative colitis	4.2e-05	0.0056	CbGpPWpGaD
Galantamine—CHRNA3—Transmission across Chemical Synapses—CALM3—ulcerative colitis	4.17e-05	0.00556	CbGpPWpGaD
Galantamine—Dizziness—Prednisone—ulcerative colitis	4.17e-05	0.00037	CcSEcCtD
Galantamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—ulcerative colitis	4.02e-05	0.00537	CbGpPWpGaD
Galantamine—Vomiting—Prednisone—ulcerative colitis	4.01e-05	0.000356	CcSEcCtD
Galantamine—ACHE—Melatonin metabolism and effects—NFKB1—ulcerative colitis	3.98e-05	0.00532	CbGpPWpGaD
Galantamine—Rash—Prednisone—ulcerative colitis	3.97e-05	0.000353	CcSEcCtD
Galantamine—Dermatitis—Prednisone—ulcerative colitis	3.97e-05	0.000353	CcSEcCtD
Galantamine—CHRNA7—Transmission across Chemical Synapses—CALM3—ulcerative colitis	3.96e-05	0.00528	CbGpPWpGaD
Galantamine—Headache—Prednisone—ulcerative colitis	3.95e-05	0.000351	CcSEcCtD
Galantamine—ACHE—Monoamine Transport—IL1B—ulcerative colitis	3.95e-05	0.00527	CbGpPWpGaD
Galantamine—CHRNA1—Transmission across Chemical Synapses—CALM3—ulcerative colitis	3.91e-05	0.00523	CbGpPWpGaD
Galantamine—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—ulcerative colitis	3.82e-05	0.0051	CbGpPWpGaD
Galantamine—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—ulcerative colitis	3.78e-05	0.00504	CbGpPWpGaD
Galantamine—Nausea—Prednisone—ulcerative colitis	3.74e-05	0.000332	CcSEcCtD
Galantamine—CHRNA2—Transmission across Chemical Synapses—CALM3—ulcerative colitis	3.72e-05	0.00496	CbGpPWpGaD
Galantamine—CHRNA6—Neuronal System—ADCY5—ulcerative colitis	3.65e-05	0.00488	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—IL10—ulcerative colitis	3.64e-05	0.00486	CbGpPWpGaD
Galantamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—ulcerative colitis	3.59e-05	0.00479	CbGpPWpGaD
Galantamine—CHRND—Neuronal System—CALM3—ulcerative colitis	3.53e-05	0.00471	CbGpPWpGaD
Galantamine—CHRNB4—Neuronal System—CALM3—ulcerative colitis	3.49e-05	0.00466	CbGpPWpGaD
Galantamine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	3.45e-05	0.0046	CbGpPWpGaD
Galantamine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	3.44e-05	0.00459	CbGpPWpGaD
Galantamine—CHRND—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	3.34e-05	0.00446	CbGpPWpGaD
Galantamine—CHRNB4—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	3.31e-05	0.00441	CbGpPWpGaD
Galantamine—CHRNA4—Transmission across Chemical Synapses—CALM3—ulcerative colitis	3.22e-05	0.0043	CbGpPWpGaD
Galantamine—CHRNB2—Neuronal System—ADCY5—ulcerative colitis	3.22e-05	0.00429	CbGpPWpGaD
Galantamine—CHRNA3—Neuronal System—CALM3—ulcerative colitis	3.19e-05	0.00426	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—PPARG—ulcerative colitis	3.12e-05	0.00416	CbGpPWpGaD
Galantamine—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—ulcerative colitis	3.11e-05	0.00415	CbGpPWpGaD
Galantamine—CHRNA7—Neuronal System—CALM3—ulcerative colitis	3.03e-05	0.00405	CbGpPWpGaD
Galantamine—CHRNA3—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	3.02e-05	0.00404	CbGpPWpGaD
Galantamine—CHRNA1—Neuronal System—CALM3—ulcerative colitis	3e-05	0.004	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	2.97e-05	0.00397	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—IL10—ulcerative colitis	2.97e-05	0.00396	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	2.91e-05	0.00389	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—MUC3A—ulcerative colitis	2.9e-05	0.00387	CbGpPWpGaD
Galantamine—CHRNA7—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	2.87e-05	0.00383	CbGpPWpGaD
Galantamine—ACHE—Monoamine Transport—TNF—ulcerative colitis	2.86e-05	0.00382	CbGpPWpGaD
Galantamine—CHRNA2—Neuronal System—CALM3—ulcerative colitis	2.85e-05	0.0038	CbGpPWpGaD
Galantamine—CHRNA1—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	2.84e-05	0.00379	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	2.8e-05	0.00373	CbGpPWpGaD
Galantamine—ACHE—ATF-2 transcription factor network—IFNG—ulcerative colitis	2.71e-05	0.00362	CbGpPWpGaD
Galantamine—CHRNA2—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	2.7e-05	0.0036	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	2.61e-05	0.00348	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—MUC3A—ulcerative colitis	2.59e-05	0.00345	CbGpPWpGaD
Galantamine—CHRND—Neuronal System—ADCY5—ulcerative colitis	2.56e-05	0.00342	CbGpPWpGaD
Galantamine—CHRNB4—Neuronal System—ADCY5—ulcerative colitis	2.53e-05	0.00338	CbGpPWpGaD
Galantamine—ACHE—ATF-2 transcription factor network—CXCL8—ulcerative colitis	2.52e-05	0.00337	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—CALM3—ulcerative colitis	2.47e-05	0.0033	CbGpPWpGaD
Galantamine—CHRNA4—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	2.34e-05	0.00312	CbGpPWpGaD
Galantamine—CHRNA3—Neuronal System—ADCY5—ulcerative colitis	2.32e-05	0.00309	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—CALM3—ulcerative colitis	2.3e-05	0.00307	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	2.29e-05	0.00306	CbGpPWpGaD
Galantamine—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	2.23e-05	0.00297	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	2.2e-05	0.00294	CbGpPWpGaD
Galantamine—CHRNA7—Neuronal System—ADCY5—ulcerative colitis	2.2e-05	0.00293	CbGpPWpGaD
Galantamine—CHRNA1—Neuronal System—ADCY5—ulcerative colitis	2.18e-05	0.0029	CbGpPWpGaD
Galantamine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	2.08e-05	0.00277	CbGpPWpGaD
Galantamine—CHRNA2—Neuronal System—ADCY5—ulcerative colitis	2.07e-05	0.00276	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	2.05e-05	0.00274	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—CALM3—ulcerative colitis	2.05e-05	0.00274	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—TNF—ulcerative colitis	2.03e-05	0.00271	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	1.99e-05	0.00266	CbGpPWpGaD
Galantamine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	1.98e-05	0.00264	CbGpPWpGaD
Galantamine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	1.98e-05	0.00264	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	1.91e-05	0.00255	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	1.86e-05	0.00248	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—ADCY5—ulcerative colitis	1.79e-05	0.00239	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	1.78e-05	0.00238	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—CALM3—ulcerative colitis	1.76e-05	0.00235	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	1.67e-05	0.00223	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—IL6—ulcerative colitis	1.64e-05	0.00219	CbGpPWpGaD
Galantamine—CYP2D6—Melatonin metabolism and effects—NFKB1—ulcerative colitis	1.63e-05	0.00218	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	1.62e-05	0.00217	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—TNF—ulcerative colitis	1.6e-05	0.00213	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—CALM3—ulcerative colitis	1.57e-05	0.0021	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	1.56e-05	0.00208	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	1.49e-05	0.00199	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—TP53—ulcerative colitis	1.46e-05	0.00195	CbGpPWpGaD
Galantamine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	1.46e-05	0.00194	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	1.45e-05	0.00194	CbGpPWpGaD
Galantamine—ACHE—ATF-2 transcription factor network—IL6—ulcerative colitis	1.42e-05	0.00189	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—MUC2—ulcerative colitis	1.42e-05	0.00189	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—TNF—ulcerative colitis	1.39e-05	0.00185	CbGpPWpGaD
Galantamine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	1.38e-05	0.00184	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—IL6—ulcerative colitis	1.34e-05	0.00178	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—IL6—ulcerative colitis	1.29e-05	0.00172	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—ADCY5—ulcerative colitis	1.28e-05	0.00171	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—MUC2—ulcerative colitis	1.26e-05	0.00169	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—PTGS1—ulcerative colitis	1.18e-05	0.00158	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CHP1—ulcerative colitis	1.18e-05	0.00158	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—ADCY5—ulcerative colitis	1.14e-05	0.00152	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—TNF—ulcerative colitis	1.13e-05	0.00151	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—IL6—ulcerative colitis	1.12e-05	0.00149	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.11e-05	0.00148	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CHP1—ulcerative colitis	1.05e-05	0.00141	CbGpPWpGaD
Galantamine—ACHE—Metabolism—DLD—ulcerative colitis	1.02e-05	0.00136	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	1.02e-05	0.00136	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	9.87e-06	0.00132	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—IL6—ulcerative colitis	9.12e-06	0.00122	CbGpPWpGaD
Galantamine—BCHE—Metabolism—DLD—ulcerative colitis	9.1e-06	0.00121	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—GHRL—ulcerative colitis	8.89e-06	0.00119	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	8.82e-06	0.00118	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—GHRL—ulcerative colitis	7.93e-06	0.00106	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	7.73e-06	0.00103	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	7.34e-06	0.00098	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	6.86e-06	0.000915	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	6.05e-06	0.000807	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—MMP1—ulcerative colitis	5.53e-06	0.000738	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	5.39e-06	0.00072	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—MMP1—ulcerative colitis	4.93e-06	0.000658	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PTGS1—ulcerative colitis	4.93e-06	0.000658	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	4.85e-06	0.000647	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CHP1—ulcerative colitis	4.85e-06	0.000647	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	4.81e-06	0.000642	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CALM3—ulcerative colitis	4.44e-06	0.000592	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PTGS1—ulcerative colitis	4.4e-06	0.000587	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	4.33e-06	0.000577	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	4.24e-06	0.000566	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—DLD—ulcerative colitis	4.18e-06	0.000558	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CALM3—ulcerative colitis	3.96e-06	0.000529	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	3.78e-06	0.000505	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—CXCL8—ulcerative colitis	3.55e-06	0.000474	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ABCB1—ulcerative colitis	3.45e-06	0.000461	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ADCY5—ulcerative colitis	3.22e-06	0.00043	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—CXCL8—ulcerative colitis	3.17e-06	0.000423	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CHP1—ulcerative colitis	3.17e-06	0.000423	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ABCB1—ulcerative colitis	3.08e-06	0.000411	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ADCY5—ulcerative colitis	2.87e-06	0.000383	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—DLD—ulcerative colitis	2.73e-06	0.000365	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PPARG—ulcerative colitis	2.4e-06	0.000321	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ALB—ulcerative colitis	2.16e-06	0.000288	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PPARG—ulcerative colitis	2.14e-06	0.000286	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PTGS1—ulcerative colitis	2.02e-06	0.00027	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ALB—ulcerative colitis	1.93e-06	0.000257	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PTGS2—ulcerative colitis	1.89e-06	0.000252	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CALM3—ulcerative colitis	1.82e-06	0.000243	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PTGS2—ulcerative colitis	1.69e-06	0.000225	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ABCB1—ulcerative colitis	1.42e-06	0.000189	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PTGS1—ulcerative colitis	1.32e-06	0.000176	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ADCY5—ulcerative colitis	1.32e-06	0.000176	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CALM3—ulcerative colitis	1.19e-06	0.000159	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PPARG—ulcerative colitis	9.85e-07	0.000131	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ABCB1—ulcerative colitis	9.26e-07	0.000124	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALB—ulcerative colitis	8.86e-07	0.000118	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ADCY5—ulcerative colitis	8.64e-07	0.000115	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PTGS2—ulcerative colitis	7.75e-07	0.000103	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PPARG—ulcerative colitis	6.44e-07	8.6e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALB—ulcerative colitis	5.79e-07	7.73e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PTGS2—ulcerative colitis	5.07e-07	6.76e-05	CbGpPWpGaD
